Nephros (NEPH) Gross Profit Growth (3y) (2013 - 2026)
Nephros (NEPH) Gross Profit Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.02 Bn | 121.80 Bn | 1.96 Bn | 18.71% |
| 2 | Becton Dickinson | 44.84 Bn | 44.03 Bn | 2.15 Bn | -1.22% |
| 3 | Alcon | 33.09 Bn | 31.43 Bn | 1.53 Bn | 5.33% |
| 4 | Medline | 32.94 Bn | 30.70 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.41 Bn | 27.75 Bn | 890.98 Mn | 12.98% |
| 6 | West Pharmaceutical Services | 23.25 Bn | 22.82 Bn | 329.20 Mn | 4.15% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -1.19% |
| 8 | Cooper Companies | 13.79 Bn | 13.65 Bn | 735.40 Mn | 8.05% |
| 9 | Align Technology | 12.07 Bn | 11.01 Bn | 736.59 Mn | 3.69% |
| 10 | Nephros | 36.43 Mn | 32.41 Mn | 2.99 Mn | 12.34% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.34% |
| Dec 31, 2025 | 22.31% |
| Sep 30, 2025 | 56.40% |
| Jun 30, 2025 | 26.07% |
| Mar 31, 2025 | 44.15% |
| Dec 31, 2024 | 18.94% |
| Sep 30, 2024 | 245.74% |
| Jun 30, 2024 | 14.46% |
| Mar 31, 2024 | 11.28% |
| Dec 31, 2023 | 15.78% |
| Sep 30, 2023 | 21.44% |
| Jun 30, 2023 | 32.44% |
| Mar 31, 2023 | 12.29% |
| Dec 31, 2022 | -7.39% |
| Sep 30, 2022 | -25.18% |
| Jun 30, 2022 | 0.68% |
| Mar 31, 2022 | 1.80% |
| Dec 31, 2021 | 15.53% |
| Sep 30, 2021 | -62.06% |
| Jun 30, 2021 | 15.38% |